CONTRIBUTION OF MITRAL-VALVE RESERVE CAPACITY TO SUSTAINED SYMPTOMATIC IMPROVEMENT AFTER BALLOON VALVULOTOMY IN MITRAL-STENOSIS - IMPLICATIONS FOR RESTENOSIS
T. Okay et al., CONTRIBUTION OF MITRAL-VALVE RESERVE CAPACITY TO SUSTAINED SYMPTOMATIC IMPROVEMENT AFTER BALLOON VALVULOTOMY IN MITRAL-STENOSIS - IMPLICATIONS FOR RESTENOSIS, Journal of the American College of Cardiology, 22(6), 1993, pp. 1691-1696
Objectives. To explain the discrepancy between the symptomatic status
of patients and the hemodynamically calculated mitral valve area durin
g long term follow up after mitral balloon valvulotomy, mitral valve o
rifice variability after dobutamine infusion was investigated in two g
roups of patients. Background. A significant increase in aortic valve
area with increased aortic transvalvular flow has been reported in pat
ients with calcific aortic stenosis after aortic balloon valvulotomy.
A similar phenomenon with regard to the mitral valve has not been stud
ied in detail. Methods. Group 1 comprised 10 patients (mean age 33 +/-
9 years) with untreated mitral stenosis. Group 2 comprised 29 consecu
tive patients (mean age 32 +/- 7 years) who underwent successful percu
taneous mitral balloon valvulotomy 13 +/- 2 months before the study. R
esults. After dobutamine infusion, heart rate and cardiac index increa
sed significantly in both groups. The mean pulmonary artery pressure,
mitral valve gradient and pulmonary capillary pressure remained unchan
ged in Group 2 but increased significantly in Group 1. The mean mitral
valve area was significantly larger in Group 2 after dobutamine infus
ion than at baseline (1.9 +/- 0.5 vs. 2.4 +/- 0.6 cm(2), p < 0.0001) b
ut was unchanged in Group 1 (1.2 +/- 0.2 vs. 1.3 +/- 0.3 cm(2), p = NS
). The mean mitral valve area in seven patients in Group 2 (24%) was l
ess than or equal to 1.5 cm(2) before dobutamine infusion (1.3 +/- 0.4
cm(2)), which was defined as restenosis. In five of these seven patie
nts who had minimal or no symptoms, the mitral valve area increased si
gnificantly after dobutamine infusion (1.3 +/- 0.1 vs. 1.9 +/- 0.1 cm(
2)). In the other two patients who were symptomatic, the mitral valve
area did not change after dobutamine infusion. These two patients were
identified as having ''true'' restenosis, and redilation of the mitra
l valve was performed in both. Conclusions. In patients who underwent
mitral balloon valvulotomy, increased mitral valve reserve capacity co
ntributed to symptomatic improvement on long-term follow-up. Dobutamin
e infusion may be helpful in detecting clinically significant restenos
is.